Innovation Spotlight: The Future of Business

A new contract gives Canadian municipalities streamlined access to robotic mowers, a high-tech solution for labor shortages and budget pressures.

With its lead drug MOLBREEVI under FDA review, Savara's upcoming investor talks are a critical test of its path from clinical trials to market.

With 14 global design awards, Geekvape isn't just winning trophies; it's rewriting the rules of product innovation in a highly competitive market.

Amid Georgia's economic boom, PEO giant FrankCrum expands, banking on its unique insurance model to win over businesses in a competitive landscape.

Memphis-based Barr Brands marks 80 years of innovation and 30 years as a 100% employee-owned company, a model for longevity and shared success.

With new CTO Sharath Pasupunuti, Sidecar Health doubles down on its AI strategy to empower consumers and challenge the traditional health insurance model.

A new feature sends a compliant text moments before an AI call, promising to boost connection rates, enhance revenue, and rebuild trust in sales outreach.

KBR lands a $149M contract to accelerate U.S. Air Force armament with advanced digital solutions, deepening its role in military modernization.

Malaysia's largest telco, CelcomDigi, launches a unified distribution system for its 20M+ users, aiming to streamline sales and enhance partner collaboration.

After a brutal cold snap, Michiganders face huge energy bills. Consumers Energy is offering aid, but it highlights a growing crisis of affordability.

A $2.5B revitalization project enters a new phase, as Vornado and Newmark aim to transform a transit hub into NYC's premier 24/7 destination.

A new platform, Accelerated Clinical Trials (ACT), promises to slash drug development timelines by up to 20 months, but faces regulatory and ethical hurdles.

The medical tech firm has confirmed it's evaluating strategic options, including a non-binding offer from Steel Partners to acquire a 51% controlling stake.

A top industry award for Paytient highlights a growing shift: insurance isn't enough. See how flexible payments are redefining access to care.

Promising Phase 2 data for a potential first-in-class neuropathic corneal pain therapy to be showcased, offering new hope for a debilitating condition.

With stronger Phase 2 data for its ATH434 drug and a healthy cash reserve, Alterity Therapeutics is preparing for a pivotal trial and seeking partners.

Investors eye Rockwell Automation's upcoming conference for insights on its software growth, AI integration, and strategy for navigating economic headwinds.

The iconic restaurant chain joins America250 with new menu items and commemorative rockers, blending comfort food with a national celebration.

AI coding assistants are nearly universal, but a new report shows speed gains come with more security flaws, hidden costs, and a developer trust deficit.

Industry leaders at the GenScript Global Forum agree: the era of AI experimentation is over. Now, the hard work of scaling and building trust begins.